<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Efficacy of Kalpaamruthaa (KA) on the modulation of inflammatory markers in <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) induced by type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> in experimental rats has been investigated in this study </plain></SENT>
<SENT sid="1" pm="."><plain><z:mp ids='MP_0003674'>Oxidative stress</z:mp> in <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> develops <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> by increasing the inflammatory markers </plain></SENT>
<SENT sid="2" pm="."><plain>Administration of KA reduced the blood <z:chebi fb="105" ids="17234">glucose</z:chebi> level towards baseline in rats with <z:mp ids='MP_0002055'>diabetes</z:mp> induced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Plasma C-reactive protein was elevated in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>, while its level was markedly reduced upon KA treatment </plain></SENT>
<SENT sid="4" pm="."><plain>Inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase and cycloxygenase-2 expressions in immunoblots, interleukin-1β and interleukin-6 expressions in reverse transcriptase polymerase chain reaction and immunohistochemical expressions of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-α and nuclear factor-κB were increased in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>-induced rats </plain></SENT>
<SENT sid="5" pm="."><plain>KA renders its protection by decreasing these inflammatory markers in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>-induced rats </plain></SENT>
<SENT sid="6" pm="."><plain>Histochemical analysis of mast cell was studied </plain></SENT>
<SENT sid="7" pm="."><plain>KA treated rats showed reduced count of mast cell in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>-induced rat myocardium </plain></SENT>
<SENT sid="8" pm="."><plain>This study provides the evidence of cardiovascular protective effect of KA in type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> through its anti-inflammatory property </plain></SENT>
</text></document>